Victory Capital Management Inc. grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Get Rating) by 1.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 103,827 shares of the company's stock after acquiring an additional 1,171 shares during the quarter. Victory Capital Management Inc.'s holdings in HCA Healthcare were worth $19,082,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Kestra Advisory Services LLC boosted its holdings in shares of HCA Healthcare by 23.1% in the 3rd quarter. Kestra Advisory Services LLC now owns 10,754 shares of the company's stock valued at $1,976,000 after buying an additional 2,015 shares during the last quarter. Fortem Financial Group LLC increased its position in shares of HCA Healthcare by 3.1% in the third quarter. Fortem Financial Group LLC now owns 2,752 shares of the company's stock worth $506,000 after purchasing an additional 82 shares during the period. Great West Life Assurance Co. Can bought a new position in shares of HCA Healthcare in the third quarter worth $36,829,000. Sentry Investment Management LLC increased its position in shares of HCA Healthcare by 6.2% in the third quarter. Sentry Investment Management LLC now owns 1,751 shares of the company's stock worth $322,000 after purchasing an additional 102 shares during the period. Finally, Park Avenue Securities LLC boosted its stake in HCA Healthcare by 0.9% in the third quarter. Park Avenue Securities LLC now owns 17,456 shares of the company's stock valued at $3,208,000 after buying an additional 164 shares in the last quarter. Institutional investors and hedge funds own 64.60% of the company's stock.
Get HCA Healthcare alerts:Insiders Place Their Bets
In other HCA Healthcare news, SVP Phillip G. Billington sold 8,332 shares of the business's stock in a transaction on Friday, October 28th. The stock was sold at an average price of $222.58, for a total value of $1,854,536.56. Following the transaction, the senior vice president now owns 40,652 shares of the company's stock, valued at $9,048,322.16. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other HCA Healthcare news, SVP Phillip G. Billington sold 8,332 shares of the business's stock in a transaction on Friday, October 28th. The stock was sold at an average price of $222.58, for a total value of $1,854,536.56. Following the transaction, the senior vice president now owns 40,652 shares of the company's stock, valued at $9,048,322.16. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider A Bruce Moore, Jr. sold 10,000 shares of the business's stock in a transaction on Friday, November 11th. The stock was sold at an average price of $224.07, for a total value of $2,240,700.00. Following the completion of the transaction, the insider now directly owns 30,807 shares in the company, valued at approximately $6,902,924.49. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 28,170 shares of company stock valued at $6,294,030. Insiders own 1.50% of the company's stock.
HCA Healthcare Trading Down 4.2 %
Shares of HCA Healthcare stock opened at $252.68 on Wednesday. The stock has a fifty day simple moving average of $243.28 and a 200 day simple moving average of $218.23. HCA Healthcare, Inc. has a 12-month low of $164.47 and a 12-month high of $279.02. The company has a market capitalization of $71.44 billion, a P/E ratio of 14.28, a price-to-earnings-growth ratio of 1.98 and a beta of 1.65.Wall Street Analyst Weigh In
Several research firms recently weighed in on HCA. Deutsche Bank Aktiengesellschaft raised their price objective on HCA Healthcare from $240.00 to $275.00 in a research note on Tuesday, January 3rd. Raymond James cut their price objective on HCA Healthcare from $250.00 to $230.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 25th. StockNews.com raised HCA Healthcare from a "buy" rating to a "strong-buy" rating in a research note on Friday, January 20th. Stephens lowered their target price on HCA Healthcare from $230.00 to $220.00 and set an "overweight" rating for the company in a report on Monday, October 24th. Finally, UBS Group lifted their target price on HCA Healthcare from $237.00 to $296.00 and gave the stock a "buy" rating in a report on Friday, January 13th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $250.25.
HCA Healthcare Profile
(Get Rating)
HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
- Get a free copy of the StockNews.com research report on HCA Healthcare (HCA)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab's First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.